Tail Bleeding Model
Tail Bleeding Model - Related Videos
08:13
Tail Vein Transection Bleeding Model in Fully Anesthetized Hemophilia A Mice
0 Views •
Cited by 6 •
2021
The refined tail vein transection (TVT) bleeding model in anesthetized mice is a sensitive in vivo method for the assessment of hemophilic bleeding. This optimized TVT bleeding model uses blood loss and bleeding time as endpoints, refining other models and avoiding death as an endpoint.
03:21
Murine Tail Lymphedema Model: An In Vivo Technique to Generate Sustained Lymphedema in Murine Tail
0 Views •
2025
This video describes an in vivo technique to generate murine tail lymphedema, an abnormal fluid accumulation in the interstitial tissue space leading to swelling in the tail. The model is applied to study mechanisms and therapy for lymphedema.
04:01
Tail Vein Injection: A Method to Administer Cancer Cells for Metastatic Studies in a Mouse Model
0 Views •
2023
This video describes a technique of injecting labeled cancer cells using tail vein injection into a mouse model. We further monitor breast cancer metastasis formation, and growth using real-time in vivo live animal imaging.
10:17
The Tail Suspension Test
0 Views •
Cited by 534 •
2012
The tail-suspension test is validated as an experimental procedure to assess antidepressant efficacy of drug treatments in mice. Mice are suspended by their tails for six minutes and escape-related behaviors are assessed. We describe procedures used in conducting the tail suspension test.
04:38
A Murine Tail Lymphedema Model
0 Views •
Cited by 20 •
2021
Lymphedema is extremity swelling caused by lymphatic dysfunction. We describe a chronic murine tail model of lymphedema and the novel use of tissue nanotransfection technology (TNT) for genetic cargo delivery to the tail.
FAQs
The measured bleeding phenotype reflects several hemostatic processes acting together. Platelet plug formation helps limit blood loss at the injury, coagulation supports stabilization of that response, and vascular reactions influence how bleeding develops. Because these mechanisms operate in vivo, the assay can connect a molecular or cellular defect with an observable whole-animal failure to control bleeding.
A defined transection creates a more consistent challenge, while warmed saline provides a standardized exposure environment during observation. These conditions help investigators compare bleeding time or blood loss across experimental groups without changing the injury or surrounding conditions arbitrarily. Standardization is therefore essential when attributing differences to biological factors or treatments rather than procedural variation.
Bleeding time records how long the animal continues to bleed, whereas blood loss indicates the quantity lost during the observation. The two measurements describe related but distinct features of hemostatic performance. Using either or both allows investigators to characterize whether an intervention or disorder changes the duration of bleeding, its extent, or both.
Treatments that alter platelet plug formation or coagulation can change the observed bleeding phenotype after the controlled injury. Comparing treated and control animals under the same conditions provides an in vivo readout of treatment-associated effects on hemostasis. This makes the assay useful for evaluating anticoagulant and antiplatelet activity, as well as potential impairment of bleeding control.
The assay is useful when researchers need to examine how a disorder affects hemostasis in an intact animal. Bleeding time and blood loss can provide measurable phenotypic outcomes for inherited or acquired abnormalities, helping relate the disorder to impaired platelet, coagulation, or vascular responses. The resulting data support comparisons between disease states and experimental controls.
The model links changes at the level of hemostatic mechanisms to a measurable bleeding phenotype. A molecular alteration, disease process, or treatment can be evaluated through its effect on bleeding after a standardized injury. This connection helps researchers determine whether mechanistic findings are associated with altered hemostatic function in the context of the whole animal.